Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Intragam P
(intravenous normal human immunoglobulin) /
CSL Behring
Welcome,
Profile
Billing
Logout
1 Disease
0 Trials
0 Trials
6 News
|
|||||||||
Intragam P
(intravenous normal human immunoglobulin) /
CSL Behring
Journal:
Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukaemia patients with hypogammaglobulinaemia and infection.
(Pubmed Central) - May 19, 2022
This study provides a globally unique insight into IgRT supply and demand in CLL patients by analysis of total national use in Australia over a 6-year period.